Show simple item record

dc.contributor.authorGremel, Gabriela
dc.contributor.authorLee, Rebecca J
dc.contributor.authorGirotti, Maria Romina
dc.contributor.authorMandal, Amit Kumar
dc.contributor.authorValpione, Sara
dc.contributor.authorGarner, G
dc.contributor.authorAyub, Mahmood
dc.contributor.authorWood, S
dc.contributor.authorRothwell, Dominic G
dc.contributor.authorFusi, Alberto
dc.contributor.authorWallace, A
dc.contributor.authorBrady, Ged
dc.contributor.authorDive, Caroline
dc.contributor.authorDhomen, Nathalie
dc.contributor.authorLorigan, Paul C
dc.contributor.authorMarais, Richard
dc.date.accessioned2016-09-06T09:34:24Z
dc.date.available2016-09-06T09:34:24Z
dc.date.issued2016-08-08
dc.identifier.citationDistinct subclonal tumour responses to therapy revealed by circulating cell-free DNA. 2016: Ann Oncolen
dc.identifier.issn1569-8041
dc.identifier.pmid27502704
dc.identifier.doi10.1093/annonc/mdw278
dc.identifier.urihttp://hdl.handle.net/10541/619874
dc.description.abstractThe application of precision medicine in oncology requires in-depth characterisation of a patient's tumours and the dynamics of their responses to treatment.
dc.languageENG
dc.language.isoenen
dc.rightsArchived with thanks to Annals of oncology : official journal of the European Society for Medical Oncology / ESMOen
dc.titleDistinct subclonal tumour responses to therapy revealed by circulating cell-free DNA.en
dc.typeArticleen
dc.contributor.departmentMolecular Oncology Group, Cancer Research UK Manchester Institute, Manchesteren
dc.identifier.journalAnnals of Oncologyen
refterms.dateFOA2018-12-17T14:38:32Z
html.description.abstractThe application of precision medicine in oncology requires in-depth characterisation of a patient's tumours and the dynamics of their responses to treatment.


Files in this item

Thumbnail
Name:
Ann Oncol-2016-Gremel-1959-65.pdf
Size:
1.122Mb
Format:
PDF
Description:
Open access full text article

This item appears in the following Collection(s)

Show simple item record